SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002169
Filing Date
2022-02-28
Accepted
2022-02-28 08:18:39
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inva-20211231.htm   iXBRL 10-K 4039060
2 EX-21.1 inva-ex21_1.htm EX-21.1 25048
3 EX-23.1 inva-ex23_1.htm EX-23.1 4211
4 EX-31.1 inva-ex31_1.htm EX-31.1 16481
5 EX-31.2 inva-ex31_2.htm EX-31.2 15543
6 EX-32 inva-ex32.htm EX-32 18343
7 GRAPHIC img10106201_0.jpg GRAPHIC 350782
  Complete submission text file 0000950170-22-002169.txt   15793764

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20211231_pre.xml EX-101.PRE 569904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20211231_def.xml EX-101.DEF 402941
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20211231_lab.xml EX-101.LAB 642350
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20211231_cal.xml EX-101.CAL 77183
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20211231.xsd EX-101.SCH 72625
79 EXTRACTED XBRL INSTANCE DOCUMENT inva-20211231_htm.xml XML 3214072
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 22684020
SIC: 2834 Pharmaceutical Preparations